'Ruxolitinib cream for the treatment of vitiligo: a randomised, controlled, phase 2 trial': a critical appraisal

Br J Dermatol. 2021 May;184(5):826-827. doi: 10.1111/bjd.19674. Epub 2021 Jan 4.

Authors

C Cotter¹, J Ferguson¹

Affiliation

¹ St John's Institute of Dermatology, King's College London, London, UK.

PMID: 33179290
DOI: 10.1111/bjd.19674

No abstract available

Publication types

Clinical Trial, Phase II
Randomized Controlled Trial

MeSH terms

Humans
Hypopigmentation*
Nitriles
Ointments
Pyrazoles
Pyrimidines
Vitiligo* / drug therapy

Substances

Nitriles
Ointments
Pyrazoles
Pyrimidines
ruxolitinib